8-K: Vivakor Restructures Debt, Extends Maturity, Issues Shares
Debt Restructuring
Vivakor, Inc. has entered into forbearance agreements with lenders to extend the maturity date of convertible notes to January 31, 2027, issue 56.17 million shares, and establish a new repayment schedule.
Summary
- Vivakor, Inc. (VIVK) entered into Forbearance and Note Amendment Agreements with seven non-affiliated accredited investors on January 30, 2026.
- These agreements address outstanding convertible promissory notes (Lender Notes) with an aggregate principal amount of $5,117,647.06, from which the company initially received $4,350,000.
- As of January 30, 2026, the company owes approximately $2,242,793 under these notes, having previously satisfied about $2,874,854 of the principal.
- The maturity date for the Lender Notes has been extended to January 31, 2027.
- Vivakor agreed to issue an aggregate of 56,167,665 shares of its restricted common stock to the lenders.
- A new repayment schedule has been established, totaling $2,234,802.97 across seven installments, with the final payment due by January 31, 2027.
- Lenders will not be permitted to convert the notes into common stock unless the company defaults on the new payment terms or fails to re-list on Nasdaq by February 28, 2026 (with a potential extension for a reverse stock split).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a necessary but challenging step for Vivakor. While it provides a temporary reprieve from immediate debt obligations and avoids immediate conversion, the significant share dilution and ongoing Nasdaq re-listing uncertainty reflect underlying financial distress.
Positives
- Maturity date of outstanding convertible notes extended to January 31, 2027, providing the company more time to repay its debt.
- Lenders have agreed to forbearance, meaning they will not exercise rights or remedies related to existing defaults, assuming the company complies with the new terms.
- Conversion of notes into common stock is restricted unless specific default conditions are met, temporarily limiting potential dilution from conversions.
Negatives
- The company is currently in default on its existing convertible promissory notes.
- Vivakor must issue 56,167,665 shares of restricted common stock to the lenders, which represents significant dilution for existing shareholders.
- The company faces a deadline of February 28, 2026, to get re-listed on Nasdaq, with failure potentially triggering immediate repayment or note conversion.
- The company is suspended from trading on Nasdaq Capital Markets.
Risks
- Failure to comply with the amended repayment terms will result in all amounts due under the notes becoming immediately payable.
- Failure to get re-listed on Nasdaq by February 28, 2026 (unless solely due to an in-process reverse stock split) will also result in all amounts due becoming immediately payable and permit note conversions.
- The company acknowledges "Existing Defaults" on its notes.
- Significant dilution risk for existing shareholders due to the issuance of 56,167,665 shares of restricted common stock.
Future Outlook
The company aims to repay its outstanding convertible notes by January 31, 2027, through a structured payment plan. A key objective is to achieve re-listing on The Nasdaq Stock Market LLC by February 28, 2026, with efforts potentially including a reverse stock split.
Management Comments
- "Vivakor acknowledges and confirms the occurrence of the Existing Defaults."
- "The Company agrees to use its best efforts to remove its suspension from trading on Nasdaq Capital Markets on or before February 28, 2026."
Industry Context
StockSavvy.ai notes that debt restructuring and forbearance agreements are common strategies for companies facing financial distress or liquidity challenges, particularly those with convertible debt. The issuance of equity to satisfy debt obligations, while dilutive, can provide immediate relief and extend runway, a frequent occurrence for smaller cap companies navigating market and operational hurdles. The Nasdaq re-listing requirement highlights the importance of maintaining exchange compliance for investor confidence and access to capital markets.
Comparison to Industry Standards
- StockSavvy.ai observes that the terms of this forbearance agreement, including the extension of maturity dates and the issuance of equity in lieu of immediate cash repayment, are consistent with typical debt restructuring efforts seen in the small-cap and micro-cap segments, especially for companies facing delisting threats.
- Similar arrangements have been observed with companies like [Hypothetical Company A] which issued a significant number of shares to convert debt, or [Hypothetical Company B] which negotiated extended payment terms to avoid bankruptcy.
- The specific dilution of 56.17 million shares against an existing share count (not provided, but implied to be substantial given the number) would need to be benchmarked against similar distressed restructurings, where dilution can often exceed 10-20% of outstanding shares.
- The requirement to re-list on Nasdaq is a standard compliance hurdle for companies that have fallen out of compliance, similar to challenges faced by [Hypothetical Company C] which underwent a reverse stock split to meet minimum bid price requirements.
Stakeholder Impact
- Shareholders: Significant dilution due to the issuance of 56,167,665 restricted common shares to lenders. Continued uncertainty regarding Nasdaq re-listing and potential further dilution if notes convert.
- Creditors (Lenders): Agreed to extend maturity and forbearance, receiving restricted shares as consideration, but retain rights to immediate repayment or conversion if new terms are breached.
- Employees: Indirect impact from company's financial stability and operational continuity.
- Customers/Suppliers: Indirect impact from company's financial stability and operational continuity.
Next Steps
- Make seven scheduled repayments to lenders, with the first due by March 1, 2026, and the last by January 31, 2027.
- Work to get re-listed on Nasdaq by February 28, 2026.
- Potentially complete a reverse stock split if it is the only remaining requirement for Nasdaq re-listing.
Key Dates
| Date | Description |
|---|---|
| 2025-06-06 | Start date of issuance period for original convertible promissory notes. |
| 2025-06-09 | End date of issuance period for original convertible promissory notes. |
| 2026-01-30 | Date Vivakor entered into Forbearance and Note Amendment Agreements with lenders. |
| 2026-02-04 | Date the 8-K report was signed. |
| 2026-02-28 | Deadline for Vivakor to get re-listed on Nasdaq, subject to extension for reverse stock split. |
| 2026-03-01 | Deadline for first repayment installment of $378,433.25. |
| 2026-04-30 | Deadline for second repayment installment of $396,414.53. |
| 2026-06-30 | Deadline for third repayment installment of $258,903.84. |
| 2026-07-31 | Deadline for fourth repayment installment of $454,796.89. |
| 2026-09-30 | Deadline for fifth repayment installment of $17,433.25. |
| 2026-10-31 | Deadline for sixth repayment installment of $356,193.98. |
| 2027-01-31 | New maturity date for the Lender Notes and deadline for final repayment installment of $372,627.23. |
Recommendation
sellThe company is in default, suspended from Nasdaq, and is issuing a substantial number of shares (56.17 million) to restructure debt, indicating severe financial distress and significant dilution for existing shareholders. While the forbearance provides a temporary lifeline, the underlying issues and the tight Nasdaq re-listing deadline with potential further dilution create high risk and uncertainty, making the stock a "sell" for seasoned investors.
Keywords
Vivakor, VIVK, debt restructuring, forbearance agreement, convertible notes, Nasdaq re-listing, equity issuance, financial default, corporate governance, restricted stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.